Coupang (CPNG) Q3 2026 Earnings Call Transcript

Coupang reported Q3 revenue of $10 billion, up 11% year over year in constant currency and above its 8%–9% growth guidance, while adjusted EBITDA was $116 million and trailing-12-month free cash flow was negative $409 million. Excluding $248 million in expenses from a July fire at one fulfillment center, consolidated gross margin was 26.7%, down 270 basis points year over year; management expects Product Commerce margins to approach pre-data-incident levels by mid-2027 and guided to 50–150 basis points of sequential adjusted EBITDA margin improvement in Q4. Developing Offerings revenue grew 27% in constant currency, with higher Taiwan investment lifting its full-year loss guidance to $1 billion–$1.1 billion; Coupang also repurchased $201 million of shares in Q3.

Analysis

The key asymmetry is operating leverage: if demand recovers into Coupang’s existing Korean fulfillment footprint, utilization and volume-linked purchasing could lift margins faster than revenue. But this is not yet a clean recovery trade: promotional intensity, supply-chain friction and fixed-cost underutilization are simultaneously depressing profitability, while Taiwan expansion adds a second, potentially longer-lived cash commitment. Management’s “temporary” characterization is a thesis to test, not a fact.

Near term (Q4): reduced reacquisition marketing and seasonal effects may improve reported margins, but one quarter of sequential improvement would not establish normalized unit economics. Over 1–3 months, watch Product Commerce adjusted EBITDA margin, gross-margin trend, and whether marketing falls without customer or revenue momentum weakening. Over 6–18 months, Taiwan’s investment could build a defensible delivery proposition—or create excess capacity and prolonged losses if customer density and repeat purchasing lag. Korean incumbents, including Naver and Baemin, could face stronger delivery competition if Coupang extends its fulfillment advantage into rapid nonfood orders; the economics of that extension remain unproven.

Contrarian point: the market may focus on the margin trough and underweight the possibility of utilization-driven recovery. Conversely, Taiwan’s fast membership growth is not proof of attractive returns; owned infrastructure and build-ahead capacity make adoption growth a poor proxy for cash-flow payback. Buybacks alongside negative trailing free cash flow also warrant scrutiny: verify liquidity, capex and repurchase funding before treating repurchases as a durable capital-return signal.

Key Decisions for Investors

• Avoid chasing a recovery solely on management’s mid-2027 normalization target. Consider a staged long in CPNG only after Q4 confirms sequential Product Commerce margin improvement and lower marketing spend does not impair customer or revenue trends; no price target without valuation and share-price context.
• Falsify the recovery thesis if Product Commerce adjusted EBITDA margin falls below the reported 4.6% Q3 level in the next quarter, or if management delays the mid-2027 margin path. Track gross margin and active-customer/spend trends alongside EBITDA to separate operating improvement from seasonal effects.
• Treat Taiwan as a watch item, not a standalone growth premium: seek evidence on repeat purchase, delivery density, unit economics and Developing Offerings cash losses before underwriting returns on accelerated infrastructure spending.
• Review cash conversion and capital allocation at the next filing: sustained negative free cash flow, rising capex, or buybacks continuing without improved operating cash flow would weaken the case that the recovery is self-funding.